During the past decade, Silverstein Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Silverstein Institute" #1 collaborator was "QST Consultations, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Silverstein Institute" are "Hearing Loss" (2 trials), "Conductive Hearing Loss" (1 trials), "Conductive and Sensori-neural Hearing Loss in the Same Ear" (1 trials), "Meniere's Disease" (1 trials) and "Otomycosis" (1 trials). Many other conditions were trialed in "Silverstein Institute" in a lesser frequency.

Most popular intervention types in "Silverstein Institute" are "Device" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "14-Day Miconazole Oil (Miconazole 2%)" (1 trials), "14-Day Placebo - Oil Vehicle" (1 trials), "7-Day Miconazole Oil (Miconazole 2%)" (1 trials), "Abbreviated Profile Hearing Aid Benefit (APHAB)" (1 trials) and "Additional follow-up visit" (1 trials). Other intervention names were less common.

The vast majority of trials in "Silverstein Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Silverstein Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Silverstein Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Silverstein Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".